Ou Wang, the former head of private equity for China Investment Corporation (CIC), has joined China Renaissance Holdings as a strategy consultant. He has also joined the board of Huajing Securities, the firm’s mainland China-focused investment banking subsidiary.
Wang will report to Fan Bao, chairman and CEO of China Renaissance. His duties include supporting the development of the firm’s investment management business, providing strategic advice to deal teams,...
KKR has offered to acquire up to 9% of First Gen Corporation, a power plant operator in the Philippines, for PHP7.29 billion ($144 million).
Japan’s Beyond Next Ventures has led a JPY800 billion ($7.4 million) Series A round for local cell-based agricultural technology specialist IntegriCulture.
Chinese drug developer Jiangsu Atom Bioscience & Pharmaceutical has raised $30 million in Series B funding led by Sequoia Capital China and Hong Kong-listed Livzon Pharmaceutical Group.
Hillhouse Capital has led an extended Series A round of funding worth $50 million for Deepexi, a Chinese start-up that provides a suite of smart data services to enterprise customers.